Solid-phase synthesis of N-substituted amidinophenoxy pyridines as factor Xa inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 14, 1998, Pages 1877-1882

  Mohan, Raju ^a   Yun, Weiya ^a   Buckman, Brad O ^a   Liang, Amy ^a   Trinh, Lan ^a   Morrissey, Michael M ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIDINE DERIVATIVE;

ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; SYNTHESIS; THROMBOCYTE AGGREGATION; THROMBOSIS;

FACTOR XA; PYRIDINES; SERINE PROTEINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032555095     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00333-3     Document Type: Article

References (13)

1. th ACS National Meeting (March 29-April 2, 1998, Dallas, TX, Abstract No. MEDI-132).
2. 2. Sturzebecher, J.; Markwardt, F.; Walsmann, P. Thromb. Res. 1976, 9, 637.
3. 3. Hauptmann, J.; Markwardt, F.; Walsmann, P. Thromb. Res. 1978, 12, 735.
4. 4. Sturzebecher, J.; Styrzebecher, U.; Vieweg, H.; Wagner, G.; Hauptmann, J.; Markwardt, P. Thromb. Res. 1989, 54, 245.
5. 5. (a) Shaw, K. J.; Guilford W. J.; Dallas, J. L.; Koovakaat, S. K.; Liang, A.; Light, D. R.; Morrissey, M. M. J. Med. Chem. In Press.
6. (b) Phillips, G. B.; Buckman, B. O.; Davey, D. D.; Eagen, K. A.; Guilford, W. J.; Hinchman, J.; Ho, E.; Koovakkat, S.; Liang, A.; Light, D. R.; Mohan, R.; Ng, H. P.; Post, J.; Smith, D.; Subramanyam, B.; Sullivan, M. E.; Trinh, L.; Vergona, R.; Walthers, J.; White, K.; Whitlow, M.; Wu, S.; Xu, W.; Morrissey, M. M. J. Med. Chem. In Press.
7. 6. Marsh, I. R.; Smith, H.; Bradley, M. J. J. Chem. Soc., Chem. Comm. 1996, 941.
8. 7. Roussel, P.; Matthews, I.; Kane, P.; Bradley, M. J. Tetrahedron Lett. 1997, 27, 4861.
9. 20 solution for 40 min. The cleavage mixture was collected in vials. The resin was washed with an additional 1 mL of the cleavage cocktail and the eluants combined in the respective vials. After transferring 50 μL of each sample into autosampler vials, the solutions were evaporated on a speed vacuum concentrator to afford the target compounds 2.
10. 9. (a) Lottenberg, R.; Christensen, U.; Jackson, C. M.; Coleman, P. L. Methods in Enzymology 1981, 80, 341.
11. (b) Morrison, J. F. Biochem. Biophys. Acta 1969, 185, 269.
12. 10. (a) Nagahara, T.; Yokoyama, Y.; Inamura, K.; Katakura, S.; Komoriya, S.; Yamaguchi, H.; Hara, T.; Iwamota, M. J. Med. Chem. 1994, 37, 1200.
13. (b) Brandstetter, H.; Kuhne, A.; Bode, W; Huber, R.; von der Saal, W.; Wirthensohn, K; Engh, R. A. J. Biol. Chem. 1996, 271, 29988.